McDermott Will & Emery advised Tissium on a Series D financing round.Tissium, a private medtech company specializing in the development of programmable biomorphic polymers for tissue…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
